HRT Financial’s Repare Therapeutics RPTX Stock Holding History

HRT Financial’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-42,301	Closed	-$109K	–	4598
2025 Q4	$109K	Buy	+42,301	New	+$85.2K	﹤0.01%	2775
2023 Q4	–	Sell	-22,834	Closed	-$275K	–	2960
2023 Q3	$275K	Buy	22,834 +8,499	+59%	+$87.7K	﹤0.01%	1703
2023 Q2	$151K	Sell	14,335 -1,659	-10%	-$17.1K	﹤0.01%	1908
2023 Q1	$157K	Sell	15,994 -6,535	-29%	-$75K	﹤0.01%	1973
2022 Q4	$331K	Buy	+22,529	New	+$337K	﹤0.01%	1671
2021 Q3	–	Sell	-12,083	Closed	-$376K	–	3692
2021 Q2	$376K	Buy	+12,083	New	+$396K	﹤0.01%	2002
2021 Q1	–	Sell	-19,683	Closed	-$675K	–	3080
2020 Q4	$675K	Buy	+19,683	New	+$588K	0.01%	868

HRT Financial's RPTX Position: Q1 2026 in Review

HRT Financial sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 42,301 shares — an estimated $109K sold.

HRT Financial first reported a position in RPTX in Q4 2020 and held it in 7 quarters. The position peaked at $675K in Q4 2020. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

HRT Financial reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
HRT Financial sold 42,301 Repare Therapeutics shares in Q1 2026, an estimated $109K.
HRT Financial first reported a position in Repare Therapeutics in Q4 2020 and held it in 7 quarters.
HRT Financial's Repare Therapeutics position peaked at $675K in Q4 2020.
0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.